INCIDENCE OF CATARACTS AFTER SINGLE FRACTION TOTAL-BODY IRRADIATION - THE ROLE OF STEROIDS AND GRAFT-VERSUS-HOST DISEASE

被引:0
|
作者
HAMON, MD
GALE, RF
MACDONALD, ID
SMITH, OP
COLLIS, CH
SKEGGS, DBL
GANDHI, L
PRENTICE, HG
机构
[1] ROYAL FREE HOSP,DEPT HAEMATOL,POND ST,LONDON NW3 2QG,ENGLAND
[2] ROYAL FREE HOSP,DEPT RADIOTHERAPY,LONDON NW3 2QG,ENGLAND
[3] UNIV LONDON SCH MED,LONDON,ENGLAND
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Eighty-eight patients who received single fraction total body irradiation (sfTBI) as part of their conditioning for allogeneic BMT have been evaluated for the risk of cataract formation. Thirty-eight (43%) have developed cataracts; 11 required surgery. With 9.5-13.6 years follow-up (median 10.7 years), all 12 recipients of unmanipulated marrow allografts have developed cateracts; the actuarial risk of needing surgery was 32 (+/- 18%, 95% confidence intervals (Cl)). Ten of these 12 required high-dose steroids (prednisolone > 1 mg/kg/day) for the treatment of GVHD. Seventy-six patients received T cell-depleted allografts; 14 of 76 required post-transplant immunosuppression with high-dose steroids. With 1-9.4 years follow-up (median 5 years), the actuarial risk of cataract formation in T cell-depleted allograft recipients is 72% (+/- 52% CI), the actuarial risk for needing surgery is 20% (+/- 9% CI). Recipients of sfTBI and non-T cell-depleted allografts had a significantly greater risk of developing cataracts (p = 0.003, log rank test) and of needing surgery (p < 0.05, log rank test) than patients receiving T cell-depleted BM. Cataracts occurred more frequently in patients requiring post-transplant immunosuppression with steroids (relative risk 2.12, p < 0.01 log rank test).
引用
收藏
页码:233 / 236
页数:4
相关论文
共 50 条
  • [31] SUBCLINICAL PULMONARY-FUNCTION DEFECTS FOLLOWING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION - RELATIONSHIP TO TOTAL-BODY IRRADIATION AND GRAFT-VERSUS-HOST DISEASE
    TAIT, RC
    BURNETT, AK
    ROBERTSON, AG
    MCNEE, S
    RIYAMI, BMS
    CARTER, R
    STEVENSON, RD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (06): : 1219 - 1227
  • [32] AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia
    Gillissen, Marijn Aletta
    Levie, Sophie E.
    de Jong, Greta
    Yasuda, Etsuko
    Bakker, Arjen Q.
    van Helden, Pauline M.
    Jefferson, Douglas M.
    Huisman, Cynthia
    Spits, Hergen
    Hazenberg, Mette D.
    BLOOD, 2015, 126 (23)
  • [33] Cyclophosphamide and total body irradiation conditioning induces IL-1 mediated graft-versus-host disease mortality
    Hill, GR
    Cooke, KR
    Crawford, JM
    Brinson, Y
    Pan, L
    Bungard, D
    Delmonte, J
    Ferrara, JLM
    BLOOD, 1997, 90 (10) : 901 - 901
  • [34] Reducing the Incidence and Severity of Acute Graft-versus-Host Disease
    Dosal, Jacquelyn
    Kirsner, Robert S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (01) : 6 - 6
  • [35] Rituximab reduces the incidence of acute graft-versus-host disease
    Christopeit, Maximilian
    Schuettee, Vincent
    Theurich, Sebastian
    Weber, Thomas
    Grothe, Wilfried
    Behre, Gerhard
    BLOOD, 2009, 113 (13) : 3130 - 3131
  • [36] STEROIDS IN THE PREVENTION AND EARLY TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
    JANSEN, J
    MCHALE, MS
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 529 - 529
  • [37] Role of Osteopontin in Acute Graft-Versus-Host Disease
    Takeda, Yasuhiro
    Nakase, Hiroshi
    Honzawa, Yusuke
    Matsumura, Kayoko
    Yamamoto, Shuji
    Yoshino, Takuya
    Uza, Norimitsu
    Ueno, Satoru
    Chiba, Tsutomu
    GASTROENTEROLOGY, 2010, 138 (05) : S259 - S259
  • [38] Incidence and Risk Factors for Fatal Graft-versus-host Disease After Liver Transplantation
    Kitajima, Toshihiro
    Henry, Matthew
    Ivanics, Tommy
    Yeddula, Sirisha
    Collins, Kelly
    Rizzari, Michael
    Yoshida, Atsushi
    Abouljoud, Marwan S.
    Nagai, Shunji
    Moonka, Dilip
    TRANSPLANTATION, 2021, 105 (12) : 2571 - 2578
  • [39] BLOOD COMPONENT IRRADIATION AND PREVENTION OF GRAFT-VERSUS-HOST DISEASE
    HEATON, A
    TRANSFUSION SCIENCE, 1995, 16 (02): : 121 - 123
  • [40] CATARACTS AFTER TOTAL-BODY IRRADIATION AND MARROW TRANSPLANTATION - A SPARING EFFECT OF DOSE FRACTIONATION
    DEEG, HJ
    FLOURNOY, N
    SULLIVAN, KM
    SHEEHAN, K
    BUCKNER, CD
    SANDERS, JE
    STORB, R
    WITHERSPOON, RP
    THOMAS, ED
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (07): : 957 - 964